# SARON (NCT02417662)

> Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02417662
- Phase: NA
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: University College, London
- Conditions: Non-small Cell Lung Cancer
- Interventions: Radical Radiotherapy (Conventional RT and SABR); Non-investigational SACT
- Enrollment: 140
- Primary outcome: Overall Survival

## Commentary we found

- X threads: 27
- Podcasts: 2
- YouTube: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=saron-nct02417662

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02417662", "email": "<work email>"}; the inbox owner confirms by the emailed link.